FDA
FDA Articles
Sorrento Therapeutics has announced that its treatment for COVID-19 had cleared its Phase 2 study in hospitalized patients with moderate to severe coronavirus infections.
Published:
PhaseBio Pharmaceuticals announced early on Friday that it has initiated its midstage study evaluating a treatment for the novel coronavirus.
Published:
The number of COVID-19 cases continues to rise, which will only create more demand for coronavirus stocks. 24/7 Wall Street has picked out a few of the best and brightest that could still see a big...
Published:
Pfizer and BioNTech have progressed in their COVID-19 vaccine effort, according to the FDA. Two of the companies’ four coronavirus vaccine candidates received Fast Track Designation.
Published:
A new research report outlines favorable Liquidia Technologies drug study data that will be presented in the coming weeks, which could add up to more than 300% potential upside.
Published:
Here is a look of a few of the biggest clinical trial and FDA updates to watch for in July 2020.
Published:
While COVID-19 pandemic is not its only target, that has been the main driver of the interest in Inovio Pharmaceuticals so far in 2020.
Published:
Alterity Therapeutics says it has received an update from the FDA regarding its Parkinson’s treatment. That made shareholders happy.
Published:
Intercept Pharmaceuticals stock was crushed early on Monday after the firm received an update from the FDA in regards to its treatment of fibrosis due to nonalcoholoic steatohepatitis.
Published:
Whenever there are new emerging trends, many companies try to get in on the action. It can create a flurry of interest from businesses and from investors alike, and to say that the coronavirus and...
Published:
Aclaris Therapeutics has received an update from FDA regarding the use of its ATI-450 in hospitalized patients with COVID-19.
Published:
The day traders are back at it, chasing stocks on news with very few thoughts about what the fundamentals may be if the good news pans out. In day trading, that just doesn’t matter because a trade...
Published:
Enochian Biosciences shares more than doubled to start out the week after the company received a critical update from the FDA regarding its HIV treatment.
Published:
FSD Pharma shares absolutely exploded on Wednesday morning after the company received a key update from the FDA.
Published:
PhaseBio Pharmaceuticals shares jumped early on Thursday after the company announced that it received an authorization from the FDA regarding its COVID-19 treatment.
Published: